73 research outputs found

    Alternative Sentencing & Strategies for Successful Prisoner Reentry

    Get PDF
    Nationally, more than two million people are serving time in prison on any given day. Missouri ranks eighth in the nation in terms of imprisonment and has experienced substantial growth in incarceration over the past two decades. The reality of mass incarceration and the accruing cost of corrections have led many states to consider implementing alternatives to traditional incarceration and parole. These alternatives between parole and confinement are often called intermediate sanctions and are intended to provide correctional options that save money and prison beds without introducing risk to public safety. The State of Missouri has made strides in developing sanctions that can serve as an alternative to prison. Section 217.777.1, RSMo, charges the Missouri Department of Corrections with the administration of a community corrections program to encourage the establishment of local sentencing initiatives and correctional alternatives. Among the goals of this legislation and alternative sanctions in general, are to: Promote the accountability of offenders to crime victims, local communities and the state; Increase the use of restitution; Reduce the costs of treatment, punishment and supervision of off enders; and Improve public confidence in the criminal justice system by involving the public in the development of community-based sentencing options for eligible offenders.Includes bibliographical reference

    Cost-Effectiveness of Early versus Late Cinacalcet Treatment in Addition to Standard Care for Secondary Renal Hyperparathyroidism in the USA

    Get PDF
    AbstractObjectivesThe objective of this research was to estimate lifetime cost-effectiveness of treating patients with cinacalcet early (when parathyroid hormone [PTH] levels are in the range of 300–500 pg/ml) versus delaying treatment with cinacalcet (cinacalcet initiated when PTH levels are >800 pg/ml) in patients with secondary hyperparathyroidism (SHPT) in the US setting.MethodsA Markov model was developed to simulate the effects of early versus delayed use of cinacalcet (plus standard of care). Four different PTH ranges (≤300 pg/ml; 301–500 pg/ml; 501–800 pg/ml; >800 pg/ml) were used to represent four different health states within the Markov model. Associated with each Markov state (PTH range) were varying risks of major SHPT complications, including cardiovascular disease (CVD), fracture (Fx), and parathyroidectomy (PTx). Baseline cohort characteristics and risks of CVD, Fx, and PTx by PTH category were derived from a large US renal database and published sources. Costs were estimated from the US Renal Data System database and reported in 2006 US Dollars ().Clinicalandeconomicoutcomeswerediscountedat3.0). Clinical and economic outcomes were discounted at 3.0% per annum.ResultsEarly treatment was projected to improve quality-adjusted life years (QALYs) by 0.337 years compared to delaying treatment. The incremental cost-effectiveness ratio was 17,275 per QALY gained.ConclusionsEarly treatment with cinacalcet was associated with improvements in QALYs and would represent good value for money compared to delaying treatment with cinacalcet

    Erythrocytosis and fatigue fractures associated with hepatoblastoma in a 3-year-old gelding

    Get PDF
    Hepatoblastoma was diagnosed in a 3-year-old Thoroughbred gelding presented with forelimb lameness with bilateral fatigue fractures of the proximal third metacarpal bones. An abdominal mass was detected on ultrasound examination of the abdomen. Absolute erythrocytosis was diagnosed after clinical and haematological evaluation. The fractured metacarpal bones were surgically removed but complications after surgery were fatal. The liver mass was diagnosed as a hepatoblastoma based on histology and immunochemical staining. The combination of hepatoblastoma and fatigue fractures has not been described previously in horses. A potential link between the hepatic and orthopaedic pathologies is hypothesised
    • …
    corecore